DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) will report first-quarter results before trading begins on January 20, 2010. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:

• At Covidien’s website: http://investor.covidien.com
• By telephone: For both “listen-only” participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 800-510-0219. For participants outside the U.S., the dial-in number is 617-614-3451. The access code for all callers is 94242633.
• Through an audio replay: A replay of the conference call will be available beginning at 11:30 a.m. on January 20, 2010, and ending at 5:00 p.m. on January 27, 2010. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 41226018.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2009 revenue in excess of $10 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.